108 related articles for article (PubMed ID: 27114939)
1. Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis.
Azeemuddin M; Rafiq M; Anturlikar SD; Sharath Kumar LM; Patki PS; Babu UV; Shyam R
J Tradit Complement Med; 2016 Apr; 6(2):160-7. PubMed ID: 27114939
[TBL] [Abstract][Full Text] [Related]
2. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study.
Mohamed IN; Sarhan NR; Eladl MA; El-Remessy AB; El-Sherbiny M
Acta Histochem; 2018 Apr; 120(3):242-254. PubMed ID: 29482933
[TBL] [Abstract][Full Text] [Related]
5. Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats.
Gerges SH; Wahdan SA; Elsherbiny DA; El-Demerdash E
Toxicol Appl Pharmacol; 2020 Aug; 401():115101. PubMed ID: 32512072
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.
Zhang W; Wu R; Zhang F; Xu Y; Liu B; Yang Y; Zhou H; Wang L; Wan K; Xiao X; Zhang X
Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1026-33. PubMed ID: 23127227
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis.
Yamada T; Kashiwagi Y; Rokugawa T; Kato H; Konishi H; Hamada T; Nagai R; Masago Y; Itoh M; Suganami T; Ogawa Y; Abe K
Magn Reson Imaging; 2019 Apr; 57():210-217. PubMed ID: 30465867
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
Duparc T; Briand F; Trenteseaux C; Merian J; Combes G; Najib S; Sulpice T; Martinez LO
Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G508-G517. PubMed ID: 31460789
[TBL] [Abstract][Full Text] [Related]
9. Ayurvedic formulation of Liv-Pro-08 reduces nonalcoholic fatty liver disease in rats fed with high-fat diet.
Suriyavathana Vedanarayanan M; Krishnan N
J Acupunct Meridian Stud; 2011 Dec; 4(4):236-41. PubMed ID: 22196506
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis.
Mohamed RH; Tarek M; Hamam GG; Ezzat SF
Eur J Pharmacol; 2019 Sep; 858():172469. PubMed ID: 31233751
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis.
Zhang W; Li C; Liu B; Wu R; Zou N; Xu YZ; Yang YY; Zhang F; Zhou HM; Wan KQ; Xiao XQ; Zhang X
Ann Hepatol; 2013; 12(6):892-900. PubMed ID: 24114819
[TBL] [Abstract][Full Text] [Related]
12. Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.
Wada T; Miyashita Y; Sasaki M; Aruga Y; Nakamura Y; Ishii Y; Sasahara M; Kanasaki K; Kitada M; Koya D; Shimano H; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1415-25. PubMed ID: 24129399
[TBL] [Abstract][Full Text] [Related]
13. Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats.
Srinivasan K; Patole PS; Kaul CL; Ramarao P
Methods Find Exp Clin Pharmacol; 2004 Jun; 26(5):327-33. PubMed ID: 15319810
[TBL] [Abstract][Full Text] [Related]
14. [Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model].
Liu J; Liu Y; Wang W; Luo Y; Zhuang Z; Jiao Q; Chen J; Bian D; Ma X; Xun Y; Zhu M; Shi J
Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):445-50. PubMed ID: 25203709
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.
Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135
[TBL] [Abstract][Full Text] [Related]
17. Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet.
Kim JH; Suk S; Jang WJ; Lee CH; Kim JE; Park JK; Kweon MH; Kim JH; Lee KW
J Food Sci; 2017 Jul; 82(7):1765-1774. PubMed ID: 28608557
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.
Wang L; Wu S; Cai M; Ma J; Li S; Li M; Xu Y; Wei L; Shang J
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820447
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats.
Chen J; Liu D; Bai Q; Song J; Guan J; Gao J; Liu B; Ma X; Du Y
Mol Med Rep; 2011; 4(5):811-6. PubMed ID: 21643627
[TBL] [Abstract][Full Text] [Related]
20. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
